Azor vs. Digoxin: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Azor and Digoxin. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 114,496 people who take Azor and Digoxin, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
114,496 people who take Azor and Digoxin are studied.
What is Azor?
Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,847 Azor users for its effectiveness, alternative drugs and more.
What is Digoxin?
Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 89,197 Digoxin users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Azor (amlodipine besylate; olmesartan medoxomil)
- Digoxin (digoxin)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Azor:
- not at all: 0.5 %
- somewhat: 15.42 %
- moderate: 30.35 %
- high: 38.31 %
- very high: 15.42 %
Digoxin:
- not at all: 2.79 %
- somewhat: 17.62 %
- moderate: 34.73 %
- high: 32.07 %
- very high: 12.8 %
Want to compare Azor with Digoxin?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Related studies
Alternative drugs to, pros and cons of:
Common Azor side effects:
- Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 423 reports
- Diarrhea: 306 reports
- Dizziness: 294 reports
- Weight decreased: 291 reports
- Constipation: 253 reports
- Chronic kidney disease: 221 reports
- Fatigue (feeling of tiredness): 209 reports
- Hiatal hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 198 reports
Browse all side effects of Azor:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Digoxin side effects:
- Breathing difficulty: 7,143 reports
- Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6,449 reports
- Fatigue (feeling of tiredness): 5,981 reports
- Weakness: 5,796 reports
- Hypotension (abnormally low blood pressure): 5,359 reports
- Dizziness: 5,355 reports
Browse all side effects of Digoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on amlodipine besylate; olmesartan medoxomil and digoxin (the active ingredients of Azor and Digoxin, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Meloxicam and Type 2 Diabetes - 4 seconds ago
- Meloxicam and Diabetes Mellitus Non-Insulin-Dependent - 4 seconds ago
- Ezetimibe and Motrin Ib drug interaction - 9 seconds ago
- Decadron and Prostatism Aggravated - 9 seconds ago
- Imvexxy and Eczema Exacerbated - 24 seconds ago
- Xtandi and Hepatomegaly - 28 seconds ago
- Levorphanol Tartrate and Itching - 31 seconds ago
- Pindolol and Renal Failure Acute - 31 seconds ago
- Vitamin B3 and Erosive Oesophagitis - 37 seconds ago
- Floxin and Stroke - 38 seconds ago